13F filer · CIK 1671207
Atlas Venture Associates IX, LLC
Boston, MA · filing since Q4 2016 · last filing Nov 13, 2023
Reported value
$11.8M
$-6.5M vs prior
Positions
6
New / sold out
2 / 2
Added / reduced
0 / 0
Turnover
17.5%
buys $2.6M · sells $3.7M
Top-10 weight
100.0%
Biggest buys vs Q2 2023
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | COHERUS BIOSCIENCES INC | +568,408 | – | +$2.1M |
| New | SYNLOGIC INC | +176,798 | – | +$496.8K |
Biggest sells vs Q2 2023
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SURFACE ONCOLOGY INC | -2,945,453 | -100.0% | $-2.6M |
| Sold out | SYNLOGIC INC | -2,651,963 | -100.0% | $-1.1M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2023
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SKILLZ INCCOM | 1,145,492 | $5.8M | 49.69% |
| 2 | COHERUS BIOSCIENCES INCCOM | 568,408 | $2.1M | 18.08% |
| 3 | SPERO THERAPEUTICS INCCOM | 1,353,303 | $1.6M | 13.93% |
| 4 | SNAP INCCL A | 150,160 | $1.3M | 11.38% |
| 5 | SYNLOGIC INCCOM | 176,798 | $496.8K | 4.23% |
| 6 | INTELLIA THERAPEUTICS INCCOM | 10,000 | $316.2K | 2.69% |